Group 1 - The core point of the news is that Rongtai Health experienced a decline of 5.34% in its stock price, reaching 35.29 CNY per share, with a trading volume of 264 million CNY and a turnover rate of 3.79%, resulting in a total market capitalization of 6.777 billion CNY [1] - Rongtai Health, established on November 15, 2002, and listed on January 11, 2017, is primarily engaged in the design, research and development, production, and sales of massage equipment [1] Group 2 - Among the top ten circulating shareholders of Rongtai Health, a fund under the Fortune Fund ranks as a significant shareholder, with the Fortune Emerging Industries Stock A/B (001048) newly entering the top ten in the second quarter, holding 2.5575 million shares, which accounts for 1.44% of the circulating shares [2] - The Fortune Emerging Industries Stock A/B (001048) was established on March 12, 2015, with a latest scale of 3.137 billion CNY. It has achieved a year-to-date return of 48.54%, ranking 189 out of 4222 in its category, and a one-year return of 120.88%, ranking 65 out of 3776 [2] Group 3 - The fund manager of Fortune Emerging Industries Stock A/B (001048) is Sun Quan, who has been in the position for 3 years and 183 days. The total asset scale of the fund is 7.75 billion CNY, with the best fund return during his tenure being 84.61% and the worst being 31.73% [3]
荣泰健康股价跌5.34%,富国基金旗下1只基金位居十大流通股东,持有255.75万股浮亏损失508.94万元